fig1

Figure 1. Hepatocarcinogenesis in patients with transfusion-dependent thalassemias (TDT). HCC: Hepatocellular carcinoma; HBV: hepatitis B virus; HCV: hepatitis C virus; ROS: reactive oxygen species; DNA: deoxyribonucleic acid.
Figure 1. Hepatocarcinogenesis in patients with transfusion-dependent thalassemias (TDT). HCC: Hepatocellular carcinoma; HBV: hepatitis B virus; HCV: hepatitis C virus; ROS: reactive oxygen species; DNA: deoxyribonucleic acid.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/